BRIEF-CSL to acquire majority stake in chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products
June 12, 2017 at 19:42 PM EDT
* CSL to acquire majority stake in chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products Source text for Eikon: Further company coverage: